NR3C1 and nonpapillary renal cell carcinoma: As shown by the clone formation assay (Fig. 8B, C) and EdU assay (Fig. 8D-F), the addition of Ceapin-A7 significantly reversed the previously reduced proliferation of ccRCC cells in the sh-NR3C1 group (P < 0.05).